Select a Meeting...

Meetings Archive For SHM Converge 2026..

Abstract Number: 792
SOCIAL DETERMINANTS OF HEALTH AND THE RISK OF PERFORATION, PERITONITIS, AND SEPSIS IN GASTROINTESTINAL MALIGNANCIES: A NATIONAL INPATIENT SAMPLE ANALYSIS
SHM Converge 2026
Background: Gastrointestinal (GI) malignancies are a leading cause of cancer mortality accounting for ~28% of cancer deaths in the U.S. [1]. Perforation, peritonitis, and septic shock are severe complications often presenting later in the disease course and associated with surgery, prolonged hospitalization, and mortality [2]. Social determinants of health (SDOH) including race, socioeconomic status, and [...]
Abstract Number: 793
THE SAFETY AND IMPACT OF INDIVIDUALIZED CARE PLANS ON HEALTHCARE UTILIZATION
SHM Converge 2026
Background: Patients living with pain associated conditions often experience a remitting and relapsing course resulting in frequent emergency department (ED) visits and hospitalizations. The optimal approach to management varies between patients and patient- centered therapy should be specific to each patient. However, healthcare fragmentation, distrust, clinician assumptions, and differences in clinician practices all contribute to [...]
Abstract Number: 794
GENDER DISPARITIES IN CLINICAL OUTCOMES OF ACUTE PANCREATITIS: A NATIONAL COHORT ANALYSIS
SHM Converge 2026
Background: Acute pancreatitis (AP) is a common cause of hospitalization in the United States. The aim of our study is to investigate the impact of gender on the outcomes of AP in adult patients hospitalized with AP. Methods: We performed a retrospective study of adult patients with AP utilizing the 2020 Nationwide Inpatient Sample (NIS) [...]
Chapter Winner
Abstract Number: 795
ASSOCIATION OF METHADONE DOSE AND TIMING WITH PATIENT-DIRECTED DISCHARGE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER
SHM Converge 2026
Background: Patient-directed discharge – defined as leaving the hospital prior to completing recommended medical treatment – is associated with increased morbidity and mortality and occurs in 10-20% of hospitalizations for patients with opioid use disorder (OUD). Patients with OUD often cite untreated pain and withdrawal as contributing to their decision to leave the hospital by [...]
Abstract Number: 796
REAL-WORLD UTILIZATION PATTERNS AND OUTCOMES IN HOSPITALIZED U.S. ADULTS WITH HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY TREATED WITH TERLIPRESSIN: A RETROSPECTIVE COHORT STUDY
SHM Converge 2026
Background: Hepatorenal syndrome-acute kidney injury (HRS-AKI), characterized by rapid deterioration in renal function, is a serious complication of decompensated cirrhosis and is associated with significant morbidity and mortality. While terlipressin is the only FDA-approved treatment in the U.S. for adults with HRS-AKI, real-world evidence on its use and outcomes remains limited. We conducted a retrospective [...]
Abstract Number: 797
IMPLEMENTATION OF A NURSE NAVIGATOR AND GROWTH OF A BEDSIDE PROCEDURE SERVICE
SHM Converge 2026
Background: As bedside procedure services become more prevalent and their impact on patient satisfaction and length of stay become evident, the volume of procedures expected of services rises. These procedures require assistance from a bedside nurse for consent, patient positioning, medication administration, and lab acquisition. This pulls nurses away from their duties to other patients [...]
Abstract Number: 798
HOSPITAL AT HOME MANAGEMENT OF ACUTE PANCREATITIS-CLINICAL CHARACTERISTICS AND OUTCOMES
SHM Converge 2026
Background: Acute pancreatitis is a common gastrointestinal condition associated with significant morbidity and healthcare utilization. Hospital at Home (HaH) programs have emerged as an alternative to traditional brick-and-mortar (B&M) hospitalization, offering hospital-level care in the home setting. While HaH has demonstrated feasibility for various conditions, clinical characteristics and outcomes for pancreatitis patients managed by HaH [...]
Abstract Number: 800
VITAMIN K IN CIRRHOSIS WITH ELEVATED INR: A SYSTEMATIC REVIEW AND META-ANALYSIS
SHM Converge 2026
Background: Vitamin K is frequently administered in cirrhosis to correct elevated INR, yet its efficacy and clinical benefit remain uncertain. We systematically reviewed and synthesized its effect on INR, responder rates, and bleeding outcomes. Methods: PubMed/PMC were searched through September 2025. Eligible studies included cirrhotic patients receiving vitamin K with reported INR or bleeding outcomes. [...]
Abstract Number: 801
AGE-FRIENDLY CARE ON HOSPITALIZATION AT HOME: HOME IS WHERE THE 4MS ARE
SHM Converge 2026
Background: In 2025, CMS implemented a new inpatient quality measure to report on age-friendly care, the 4Ms Framework: what matters, medications, mentation, and mobility. Hospitalization at Home (HaH) provides hospital-level care to patients in the comfort of their own homes. This study assesses whether HaH delivers age-friendly care aligned with the 4Ms Framework. Methods: We [...]
Abstract Number: 802
RISK FACTORS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER DISEASE
SHM Converge 2026
Background: Patients with liver disease have complex hemostatic abnormalities that can cause severe hematologic complications. Although they are known to be at increased risk for bleeding, newer evidence has dispelled the notion that they are protected from venous thromboembolism (VTE). Liver disease is also associated with multiple complications, such as varices, ascites, and hepatic encephalopathy, [...]